Which has better valuation and earnings, TEM or LH?

Labcorp has higher revenue and earnings than Tempus AI. Tempus AI is trading at a lower price-to-earnings ratio than Labcorp, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Tempus AI $1.27B 8.37 -$245.03M -$1.44 N/A Labcorp $13.95B 1.81 $876.50M $12.09 25.75

Is TEM or LH more profitable?

Labcorp has a net margin of 6.99% compared to Tempus AI's net margin of -17.77%. Labcorp's return on equity of 16.74% beat Tempus AI's return on equity. Company Net Margins Return on Equity Return on Assets Tempus AI -17.77% -50.28% -10.33% Labcorp 6.99% 16.74% 7.81%

Does the media favor TEM or LH?

In the previous week, Tempus AI had 8 more articles in the media than Labcorp. MarketBeat recorded 29 mentions for Tempus AI and 21 mentions for Labcorp. Tempus AI's average media sentiment score of 0.65 beat Labcorp's score of 0.58 indicating that Tempus AI is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tempus AI 7 Very Positive mention(s) 4 Positive mention(s) 11 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive Labcorp 9 Very Positive mention(s) 2 Positive mention(s) 8 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer TEM or DGX?

In the previous week, Tempus AI had 14 more articles in the media than Quest Diagnostics. MarketBeat recorded 29 mentions for Tempus AI and 15 mentions for Quest Diagnostics. Quest Diagnostics' average media sentiment score of 1.21 beat Tempus AI's score of 0.65 indicating that Quest Diagnostics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tempus AI 7 Very Positive mention(s) 4 Positive mention(s) 11 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive Quest Diagnostics 10 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher earnings and valuation, TEM or GH?

Tempus AI has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Tempus AI, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Tempus AI $1.27B 8.37 -$245.03M -$1.44 N/A Guardant Health $1.18B 17.85 -$416.28M -$3.49 N/A

Does the media prefer TEM or GH?

In the previous week, Tempus AI had 12 more articles in the media than Guardant Health. MarketBeat recorded 29 mentions for Tempus AI and 17 mentions for Guardant Health. Guardant Health's average media sentiment score of 0.81 beat Tempus AI's score of 0.65 indicating that Guardant Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tempus AI 7 Very Positive mention(s) 4 Positive mention(s) 11 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive Guardant Health 7 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer TEM or BTSG?

In the previous week, Tempus AI had 21 more articles in the media than BrightSpring Health Services. MarketBeat recorded 29 mentions for Tempus AI and 8 mentions for BrightSpring Health Services. BrightSpring Health Services' average media sentiment score of 1.13 beat Tempus AI's score of 0.65 indicating that BrightSpring Health Services is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tempus AI 7 Very Positive mention(s) 4 Positive mention(s) 11 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Positive BrightSpring Health Services 6 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Tempus AI (TEM) Competitors

$59.01 +0.27 (+0.46%)

Closing price 09/11/2026 04:00 PM Eastern

Extended Trading

$59.00 -0.01 (-0.02%)

As of 09/11/2026 07:59 PM Eastern

Compare

TEM vs. LH, DGX, GH, FMS, and BTSG

Should you buy Tempus AI stock or one of its competitors? Tempus AI's main competitors and comparable companies include Labcorp (LH), Quest Diagnostics (DGX), Guardant Health (GH), Fresenius Medical Care AG & Co. KGaA (FMS), and BrightSpring Health Services (BTSG). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does Tempus AI compare to Labcorp?

Tempus AI (NASDAQ:TEM) and Labcorp (NYSE:LH) are both large-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, valuation, media sentiment, analyst recommendations, profitability, dividends, institutional ownership and risk.

Tempus AI has a beta of 3.72, suggesting that its stock price is 272% more volatile than the broader market. Comparatively, Labcorp has a beta of 0.88, suggesting that its stock price is 12% less volatile than the broader market.

Labcorp has a net margin of 6.99% compared to Tempus AI's net margin of -17.77%. Labcorp's return on equity of 16.74% beat Tempus AI's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tempus AI	-17.77%	-50.28%	-10.33%
Labcorp	6.99%	16.74%	7.81%

In the previous week, Tempus AI had 8 more articles in the media than Labcorp. MarketBeat recorded 29 mentions for Tempus AI and 21 mentions for Labcorp. Tempus AI's average media sentiment score of 0.65 beat Labcorp's score of 0.58 indicating that Tempus AI is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Tempus AI	7 Very Positive mention(s)	4 Positive mention(s)	11 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive
Labcorp	9 Very Positive mention(s)	2 Positive mention(s)	8 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

Tempus AI currently has a consensus price target of $69.33, suggesting a potential upside of 17.49%. Labcorp has a consensus price target of $336.36, suggesting a potential upside of 8.03%. Given Tempus AI's higher probable upside, equities analysts plainly believe Tempus AI is more favorable than Labcorp.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tempus AI	2 Sell rating(s)	8 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.43
Labcorp	0 Sell rating(s)	3 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.75

24.2% of Tempus AI shares are held by institutional investors. Comparatively, 95.9% of Labcorp shares are held by institutional investors. 24.3% of Tempus AI shares are held by insiders. Comparatively, 0.8% of Labcorp shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Labcorp has higher revenue and earnings than Tempus AI. Tempus AI is trading at a lower price-to-earnings ratio than Labcorp, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tempus AI	$1.27B	8.37	-$245.03M	-$1.44	N/A
Labcorp	$13.95B	1.81	$876.50M	$12.09	25.75

Summary

Labcorp beats Tempus AI on 9 of the 16 factors compared between the two stocks.

How does Tempus AI compare to Quest Diagnostics?

Tempus AI (NASDAQ:TEM) and Quest Diagnostics (NYSE:DGX) are both large-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, risk, institutional ownership, valuation, profitability, dividends, earnings and analyst recommendations.

Tempus AI currently has a consensus target price of $69.33, indicating a potential upside of 17.49%. Quest Diagnostics has a consensus target price of $236.31, indicating a potential upside of 0.64%. Given Tempus AI's higher probable upside, equities analysts clearly believe Tempus AI is more favorable than Quest Diagnostics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tempus AI	2 Sell rating(s)	8 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.43
Quest Diagnostics	0 Sell rating(s)	7 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.54

Quest Diagnostics has higher revenue and earnings than Tempus AI. Tempus AI is trading at a lower price-to-earnings ratio than Quest Diagnostics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tempus AI	$1.27B	8.37	-$245.03M	-$1.44	N/A
Quest Diagnostics	$11.04B	2.35	$992M	$9.42	24.93

24.2% of Tempus AI shares are owned by institutional investors. Comparatively, 88.1% of Quest Diagnostics shares are owned by institutional investors. 24.3% of Tempus AI shares are owned by company insiders. Comparatively, 0.9% of Quest Diagnostics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, Tempus AI had 14 more articles in the media than Quest Diagnostics. MarketBeat recorded 29 mentions for Tempus AI and 15 mentions for Quest Diagnostics. Quest Diagnostics' average media sentiment score of 1.21 beat Tempus AI's score of 0.65 indicating that Quest Diagnostics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Tempus AI	7 Very Positive mention(s)	4 Positive mention(s)	11 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive
Quest Diagnostics	10 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Quest Diagnostics has a net margin of 9.18% compared to Tempus AI's net margin of -17.77%. Quest Diagnostics' return on equity of 16.01% beat Tempus AI's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tempus AI	-17.77%	-50.28%	-10.33%
Quest Diagnostics	9.18%	16.01%	7.27%

Tempus AI has a beta of 3.72, meaning that its stock price is 272% more volatile than the broader market. Comparatively, Quest Diagnostics has a beta of 0.55, meaning that its stock price is 45% less volatile than the broader market.

Summary

Quest Diagnostics beats Tempus AI on 11 of the 17 factors compared between the two stocks.

How does Tempus AI compare to Guardant Health?

Tempus AI (NASDAQ:TEM) and Guardant Health (NASDAQ:GH) are both large-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, media sentiment, valuation, risk, dividends, analyst recommendations, institutional ownership and earnings.

24.2% of Tempus AI shares are held by institutional investors. Comparatively, 92.6% of Guardant Health shares are held by institutional investors. 24.3% of Tempus AI shares are held by company insiders. Comparatively, 5.6% of Guardant Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Tempus AI has a net margin of -17.77% compared to Guardant Health's net margin of -38.33%. Guardant Health's return on equity of 0.00% beat Tempus AI's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tempus AI	-17.77%	-50.28%	-10.33%
Guardant Health	-38.33%	N/A	-25.40%

Tempus AI has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Tempus AI, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tempus AI	$1.27B	8.37	-$245.03M	-$1.44	N/A
Guardant Health	$1.18B	17.85	-$416.28M	-$3.49	N/A

Tempus AI has a beta of 3.72, suggesting that its stock price is 272% more volatile than the broader market. Comparatively, Guardant Health has a beta of 1.57, suggesting that its stock price is 57% more volatile than the broader market.

In the previous week, Tempus AI had 12 more articles in the media than Guardant Health. MarketBeat recorded 29 mentions for Tempus AI and 17 mentions for Guardant Health. Guardant Health's average media sentiment score of 0.81 beat Tempus AI's score of 0.65 indicating that Guardant Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Tempus AI	7 Very Positive mention(s)	4 Positive mention(s)	11 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive
Guardant Health	7 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Tempus AI presently has a consensus target price of $69.33, suggesting a potential upside of 17.49%. Guardant Health has a consensus target price of $188.13, suggesting a potential upside of 19.54%. Given Guardant Health's stronger consensus rating and higher probable upside, analysts plainly believe Guardant Health is more favorable than Tempus AI.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tempus AI	2 Sell rating(s)	8 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.43
Guardant Health	1 Sell rating(s)	0 Hold rating(s)	24 Buy rating(s)	1 Strong Buy rating(s)	2.96

Summary

Tempus AI beats Guardant Health on 9 of the 17 factors compared between the two stocks.

How does Tempus AI compare to Fresenius Medical Care AG & Co. KGaA?

Tempus AI (NASDAQ:TEM) and Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) are both large-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, risk, media sentiment, profitability, dividends, valuation, institutional ownership and earnings.

In the previous week, Tempus AI had 29 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 29 mentions for Tempus AI and 0 mentions for Fresenius Medical Care AG & Co. KGaA. Tempus AI's average media sentiment score of 0.65 beat Fresenius Medical Care AG & Co. KGaA's score of 0.00 indicating that Tempus AI is being referred to more favorably in the media.

Company	Overall Sentiment
Tempus AI	Positive
Fresenius Medical Care AG & Co. KGaA	Neutral

Tempus AI currently has a consensus target price of $69.33, suggesting a potential upside of 17.49%. Fresenius Medical Care AG & Co. KGaA has a consensus target price of $23.57, suggesting a potential upside of 5.42%. Given Tempus AI's stronger consensus rating and higher possible upside, analysts plainly believe Tempus AI is more favorable than Fresenius Medical Care AG & Co. KGaA.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tempus AI	2 Sell rating(s)	8 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.43
Fresenius Medical Care AG & Co. KGaA	5 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.55

Tempus AI has a beta of 3.72, indicating that its share price is 272% more volatile than the broader market. Comparatively, Fresenius Medical Care AG & Co. KGaA has a beta of 0.76, indicating that its share price is 24% less volatile than the broader market.

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.83% compared to Tempus AI's net margin of -17.77%. Fresenius Medical Care AG & Co. KGaA's return on equity of 9.28% beat Tempus AI's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tempus AI	-17.77%	-50.28%	-10.33%
Fresenius Medical Care AG & Co. KGaA	4.83%	9.28%	4.16%

24.2% of Tempus AI shares are owned by institutional investors. Comparatively, 8.4% of Fresenius Medical Care AG & Co. KGaA shares are owned by institutional investors. 24.3% of Tempus AI shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Tempus AI. Tempus AI is trading at a lower price-to-earnings ratio than Fresenius Medical Care AG & Co. KGaA, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tempus AI	$1.27B	8.37	-$245.03M	-$1.44	N/A
Fresenius Medical Care AG & Co. KGaA	$22.20B	0.54	$1.11B	$1.93	11.58

Summary

Tempus AI beats Fresenius Medical Care AG & Co. KGaA on 9 of the 16 factors compared between the two stocks.

How does Tempus AI compare to BrightSpring Health Services?

Tempus AI (NASDAQ:TEM) and BrightSpring Health Services (NASDAQ:BTSG) are both large-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, valuation, risk, institutional ownership, analyst recommendations, media sentiment, earnings and profitability.

BrightSpring Health Services has a net margin of 2.55% compared to Tempus AI's net margin of -17.77%. BrightSpring Health Services' return on equity of 16.73% beat Tempus AI's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tempus AI	-17.77%	-50.28%	-10.33%
BrightSpring Health Services	2.55%	16.73%	5.24%

24.2% of Tempus AI shares are held by institutional investors. 24.3% of Tempus AI shares are held by company insiders. Comparatively, 2.8% of BrightSpring Health Services shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Tempus AI has a beta of 3.72, indicating that its stock price is 272% more volatile than the broader market. Comparatively, BrightSpring Health Services has a beta of 1.84, indicating that its stock price is 84% more volatile than the broader market.

Tempus AI currently has a consensus target price of $69.33, indicating a potential upside of 17.49%. BrightSpring Health Services has a consensus target price of $70.71, indicating a potential upside of 20.39%. Given BrightSpring Health Services' stronger consensus rating and higher possible upside, analysts plainly believe BrightSpring Health Services is more favorable than Tempus AI.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tempus AI	2 Sell rating(s)	8 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.43
BrightSpring Health Services	0 Sell rating(s)	0 Hold rating(s)	18 Buy rating(s)	2 Strong Buy rating(s)	3.10

BrightSpring Health Services has higher revenue and earnings than Tempus AI. Tempus AI is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tempus AI	$1.27B	8.37	-$245.03M	-$1.44	N/A
BrightSpring Health Services	$12.91B	0.90	$190.67M	$1.66	35.38

In the previous week, Tempus AI had 21 more articles in the media than BrightSpring Health Services. MarketBeat recorded 29 mentions for Tempus AI and 8 mentions for BrightSpring Health Services. BrightSpring Health Services' average media sentiment score of 1.13 beat Tempus AI's score of 0.65 indicating that BrightSpring Health Services is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Tempus AI	7 Very Positive mention(s)	4 Positive mention(s)	11 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive
BrightSpring Health Services	6 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

BrightSpring Health Services beats Tempus AI on 12 of the 17 factors compared between the two stocks.

Get Tempus AI News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TEM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

TEM vs. The Competition

Export

Metric	Tempus AI	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$10.60B	$9.87B	$7.16B	$12.72B
Dividend Yield	N/A	2.61%	2.56%	11.15%
P/E Ratio	-40.98	33.27	272.98	25.27
Price / Sales	8.37	4.85	606.62	75.32
Price / Cash	N/A	125.76	77.04	51.44
Price / Book	21.38	5.29	10.33	6.20
Net Income	-$245.03M	$313.25M	$3.49B	$358.27M
7 Day Performance	-8.68%	-1.26%	-3.33%	-2.35%
1 Month Performance	8.06%	-0.98%	-0.40%	-2.77%
1 Year Performance	-31.69%	15.13%	19.15%	7.64%

Tempus AI Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
TEM Tempus AI	3.0243 of 5 stars	$59.01 +0.5%	$69.33 +17.5%	-33.5%	$10.60B	$1.27B	N/A	3,800	Trending News Analyst Forecast
LH Labcorp	4.1191 of 5 stars	$329.27 -0.7%	$330.00 +0.2%	+11.2%	$26.69B	$13.95B	27.22	71,000	Trending News Analyst Forecast
DGX Quest Diagnostics	4.4237 of 5 stars	$238.10 -0.5%	$235.31 -1.2%	+27.8%	$26.27B	$11.04B	25.27	57,000	Positive News Analyst Forecast Analyst Revision
GH Guardant Health	3.3057 of 5 stars	$155.52 -3.4%	$183.78 +18.2%	+177.1%	$20.94B	$982.02M	N/A	2,506	Analyst Forecast
FMS Fresenius Medical Care AG & Co. KGaA	2.1801 of 5 stars	$22.77 +1.3%	$23.57 +3.5%	-11.6%	$12.22B	$22.20B	11.79	1,488

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:TEM) was last updated on 9/12/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Tempus AI (TEM) Competitors

TEM vs. LH, DGX, GH, FMS, and BTSG

How does Tempus AI compare to Labcorp?

Summary

How does Tempus AI compare to Quest Diagnostics?

Summary

How does Tempus AI compare to Guardant Health?

Summary

How does Tempus AI compare to Fresenius Medical Care AG & Co. KGaA?

Summary

How does Tempus AI compare to BrightSpring Health Services?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TEM vs. The Competition

Tempus AI Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Tempus AI (TEM) Competitors

TEM vs. LH, DGX, GH, FMS, and BTSG

How does Tempus AI compare to Labcorp?

Which has more volatility & risk, TEM or LH?

Is TEM or LH more profitable?

Does the media favor TEM or LH?

Do analysts recommend TEM or LH?

Do insiders and institutionals hold more shares of TEM or LH?

Which has better valuation and earnings, TEM or LH?

Summary

How does Tempus AI compare to Quest Diagnostics?

Do analysts rate TEM or DGX?

Which has higher valuation & earnings, TEM or DGX?

Do insiders & institutionals believe in TEM or DGX?

Does the media prefer TEM or DGX?

Is TEM or DGX more profitable?

Which has more volatility & risk, TEM or DGX?

Summary

How does Tempus AI compare to Guardant Health?

Do insiders & institutionals hold more shares of TEM or GH?

Is TEM or GH more profitable?

Which has higher earnings and valuation, TEM or GH?

Which has more risk & volatility, TEM or GH?

Does the media prefer TEM or GH?

Do analysts rate TEM or GH?

Summary

How does Tempus AI compare to Fresenius Medical Care AG & Co. KGaA?

Does the media refer more to TEM or FMS?

Do analysts recommend TEM or FMS?

Which has more risk and volatility, TEM or FMS?

Is TEM or FMS more profitable?

Do institutionals & insiders hold more shares of TEM or FMS?

Which has better earnings and valuation, TEM or FMS?

Summary

How does Tempus AI compare to BrightSpring Health Services?

Is TEM or BTSG more profitable?

Do institutionals and insiders believe in TEM or BTSG?

Which has more risk & volatility, TEM or BTSG?

Do analysts recommend TEM or BTSG?

Which has preferable valuation & earnings, TEM or BTSG?

Does the media prefer TEM or BTSG?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TEM vs. The Competition

Tempus AI Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools